Skip to main content
U.S. flag

An official website of the United States government

HIV Research Program

Provide input on HIV research priorities until March 28, 2024: The NIH Office of AIDS Research is seeking input to inform development of the FY 2026‒2030 NIH Strategic Plan for HIV and HIV-Related Research. Learn more, and contribute by March 28, 2024. 

Early Career Investigator Resources

Two female scientists working with test tubes and a microscope

The National Institutes of Health (NIH) Office of AIDS Research (OAR) coordinates HIV/AIDS research across NIH. The NIH provides the largest public investment in HIV/AIDS research globally. NIH OAR supports and promotes diversity to advance research and enhance innovation to end the HIV pandemic. As stated in the NIH Strategic Plan for HIV and HIV-Related Research, Goal 4 is to “build human resource and infrastructure capacity to enhance sustainability of HIV research discovery and the implementation of findings by a diverse and multidisciplinary workforce.”

To advance these goals, NIH OAR conducted multiple stakeholder events and gathered comprehensive input (2020 OAR Stakeholder Outreach Report and 2021 OAR Stakeholder Outreach Report) on how to improve outreach to the next generation of HIV investigators and effectively address training and capacity-building programs. In response to the significant input received, NIH OAR developed an HIV early career investigator page to centralize relevant information for investigators and provide easy access to grant opportunities, basic information, and other resources, such as training and capacity building programs.

Events for Early Career Investigators

OAR Director’s Seminar: Join the NIH Office of AIDS Research (OAR) for a live, virtual OAR Director’s Seminar, “The Last Gift Program: Lessons Learned From Altruistic Participants Enrolled in HIV Cure Research at the End of Life” on April 5 from 1-2:30 p.m. ET to hear Sara Gianella Weibel, M.D., discuss her impactful contributions as an early career investigator (ECI) in HIV across priority areas such as HIV reservoir, transmission, coinfection, and sex- and gender-related issues. Learn more, or register now for this live seminar.  

2024 Workshop for Early Career Investigators in HIV: The NIH Office of AIDS Research, in partnership with offices across NIH, will hold the third annual virtual workshop for students, postdocs, and new HIV investigators on Wednesday, April 24, 2024, from 11 a.m.–4 p.m. ET. Register and find updates on the event webpage, or learn about the 2023 workshop.

  • NIH OAR Data Hub
    • Explore the NIH HIV research portfolio with a new tool that allows users to search and filter awarded projects by research topic, funding opportunity, organization, and more.
  • NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding
    • Find information from NIH OAR about NIH HIV/AIDS research priorities and guidelines for allocation of HIV funding for fiscal years 2021-2025.
  • NIH Grants and Funding
    • Find application instructions and guidance to submit grant applications to the NIH, the Centers for Disease Control and Prevention, the Food and Drug Administration, and the Agency for Healthcare Research and Quality.
    • Listen to the NIH All About Grants Podcasts to hear about the ins and outs of NIH funding and get insights on grant topics.
  • NIH Research Training and Career Development
    • Explore individual and institutional NIH research training and career development (K award) opportunities at the undergraduate, graduate, and postdoctoral levels.
  • Save the date for the 2024 NIH OAR Workshop for Early Career Investigators in HIV on April 24, 2024.
    • Learn about our 2023 event.

Use these dates and resources to guide your grant submission plans.

Visit the NIH ICO websites to learn about HIV research and funding opportunities, such as the following –

Learn more about the programs, conferences, and opportunities offered by NIH.

The HIV Vaccine Trials Network (HVTN) is the world’s largest publicly funded multi-disciplinary international collaboration facilitating the development of vaccines to prevent HIV/AIDS. The HVTN conducts all phases of clinical trials, from evaluating experimental vaccines for safety and immunogenicity to testing vaccine efficacy. Explore HVTN to learn about opportunities and programs for new investigators such as the Scholar Awards.

  • Scholar Awards: The Research and Mentorship Program (RAMP) aims to recruit and retain a new generation of HIV vaccine researchers by providing structured mentorship and project funding to African American/Black and Latinx U.S. medical students.
  • Submit an Idea or Proposal: HVTN welcomes the ideas of the scientific community regarding new proposals for HIV vaccine studies that are not currently being planned or pursued.
  • Ancillary/Exploratory Studies: The HVTN shares data and specimens collected in its studies with investigators who would like to use HVTN’s materials to answer research questions related to vaccinology, immunology, or HIV/AIDS.

These visuals outline career path options and examples of NIH-funded mechanisms available to individuals in different stages of their careers. There are a variety of paths to pursue. For more information about individual funding mechanisms, see NIH Research Training and Career Development Programs.

Career path for scientists with PhD degrees, including opportunities for undergraduate, graduate students, postdoctoral fellows and early career assistant professors.

Career path for scientists with Medical degrees, including opportunities for undergraduates, medical students, clinical fellows and early career assistant professors.

HIV Funding Opportunities

This list of Funding Opportunity Announcements (FOAs) may include HIV/AIDS receipt dates. Please note that some FOAs allow HIV/AIDS applications but they may have specific requests such as all AIMS should be related to HIV research. Contact the Program Officer indicated in the individual funding opportunity to request further details.

This page last reviewed on March 7, 2024